Link between metformin and the peroxisome proliferator-activated receptor γ pathway in the uterine tissue of hyperandrogenized prepubertal mice

Fertility and Sterility

Volumn 95, Issue 8, 2011, Pages

  Elia, Evelin M ^a   Pustovrh, Carolina ^b,c   Amalfi, Sabrina ^a   Devoto, Luigi ^c   Motta, Alicia Beatriz ^a  

^a CONICET ^*  (Argentina)

^b INSTITUTO DE FISIOLOGÍA   (Argentina)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

Lipoxygenases; metformin; peroxisome proliferator activated receptor gamma; polycystic ovary syndrome; uterus

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME SYNTHESIS; FEMALE; GENE EXPRESSION; HYPERANDROGENISM; MOUSE; NONHUMAN; PREPUBERTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; UTERUS;

EID: 79959749781     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2011.02.004     Document Type: Article

References (38)

1. S. Franks Polycystic ovary syndrome N Engl J Med 333 1995 853 861
2. M.A. Okon, S.M. Laird, E.M. Tuckerman, and T.C. Li Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function Fertil Steril 69 1998 682 690 (Pubitemid 28188464)
3. E.M. Tuckerman, M.A. Okon, T. Li, and S.M. Laird Do androgens have a direct effect on endometrial function? An in vitro study Fertil Steril 74 2000 771 779
4. T. Sir-Petermann, M. Maliqueo, B. Angel, H.E. Lara, F. Perez-Bravo, and S.E. Recabarren Maternal serum androgens in pregnant women with polycystic ovary syndrome: possible implications in prenatal androgenization Hum Reprod 17 2002 2573 2579 (Pubitemid 35174106)
5. A.H. Balen, S.L. Tan, J. McDougall, and H.S. Jacobs Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovary syndrome and reduced by pituitary desensitization with buserelin Hum Reprod 8 1993 959 964 (Pubitemid 23193697)
6. O.C. Pillay, L.F. Te Fong, J.C. Crow, E. Benjamin, T. Mould, and W. Atiomo The association between polycystic ovaries and endometrial cancer Hum Reprod 21 2006 924 929
7. E. Elia, S. Vighi, E. Lombardi, and A.B. Motta Detrimental effects of hyperandrogenism on uterine functions Int Immunopharmacol 8 2008 1827 1834
8. E.M. Elia, D. Belgorosky, M. Faut, S. Vighi, C. Pustovrh, and L. Devoto The effects of metformin on uterine tissue of hyperandrogenized BALB/c mice Mol Hum Reprod 15 2009 421 432
9. V. Sander, M.E. Solano, E. Elia, C.G. Luchetti, G. Di Girolamo, and C. Gonzalez The influence of dehydroepiandrosterone on early pregnancy in mice Neuroimmunomodulation 12 2005 285 292 (Pubitemid 41318211)
10. M.E. Solano, V. Sander, E. Elia, C.G. Luchetti, G. Di Girolamo, and C. Gonzalez Metformin prevents embryonic resorption induced by hyperandrogenization with dehydroepiandrosterone in mice Reprod Fertil Dev 18 2006 533 544 (Pubitemid 43806922)
11. C.G. Luchetti, E. Mikó, J. Szekeres-Bartho, D.A. Paz, and A.B. Motta Dehydroepiandrosterone and metformin modulate progesterone induced blocking factor (PIBF), cyclooxygenase 2 (COX2) and cytokines in early pregnant mice J Steroid Biochem Mol Biol 111 2008 200 207
12. G. Zhou, R. Myers, Y. Li, Y. Chen, X. Shen, and J. Fenyk-Melody Role of AMP-activated protein kinase in mechanism of metformin action J Clin Invest 108 2001 1167 1174 (Pubitemid 32995375)
13. L.G. Fryer, A. Parbu-Patel, and D. Carling The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways J Biol Chem 12 2002 25226 25232 (Pubitemid 34951829)
14. M.H. Zou, S.S. Kirkpatrick, B.J. Davis, J.S. Nelson, W.G. Wiles, and U. Schlattner Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo J Biol Chem 279 2004 43940 43951
15. E. Diamanti-Kandarakis, C. Kouli, T. Tsianateli, and A. Bergiele Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome Eur J Endocrinol 138 1998 269 274 (Pubitemid 28154775)
16. C.J. Glueck, R.N. Fontaine, P. Wang, M.T. Subbiah, K. Weber, and E. Illig Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30 Metabolism 50 2001 856 861 (Pubitemid 32700469)
17. D.J. Jakubowicz, M. Seppälä, S. Jakubowicz, O. Rodriguez-Armas, A. Rivas-Santiago, and H. Koistinen Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome J Clin Endocrinol Metab 86 2001 1126 1133 (Pubitemid 32322992)
18. A. La Marca, G. Morgante, M. Palumbo, A. Cianci, F. Petraglia, and V. De Leo Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with polycystic ovary syndrome Fertil Steril 78 2002 1234 1239 (Pubitemid 35463120)
19. E. Velázquez, A. Acosta, and S.G. Mendoza Menstrual cyclicity after metformin therapy in polycystic ovary syndrome Obstet Gynecol 90 1997 392 395 (Pubitemid 27357930)
20. C.J. Glueck, N. Goldenberg, P. Wang, M. Loftspring, and A. Sherman Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy Hum Reprod 19 2004 510 521 (Pubitemid 38344509)
21. I. Issemann, and S. Green Activation of a member of the steroid hormonal receptor superfamily by peroxisome proliferators Nature 347 1990 645 650
22. P. Needleman, J. Turk, B.A. Jakschik, A.R. Morrison, and J.B. Lefkowith Arachidonic acid and metabolism Annu Rev Biochem 55 1986 69 102
23. H. Kuhn, and S. Borngraber Mammalian 15-lipoxygenases: enzyme properties and biological implications S. Nigam, C.R. Pace-Asciak, Lipoxygenases and their metabolites 447 1999 Plenum New York 5 28 (Pubitemid 32448218)
24. A.R. Brash Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate J Biol Chem 274 1999 23679 23682
25. D.J. Conrad The arachidonate 12/15 lipoxygenases: a review of tissue expression and biologic function Clin Rev Allergy Immunol 17 1999 71 89 (Pubitemid 29349935)
26. Q. Li, Y.P. Cheon, A. Kannan, S. Shanker, I.C. Bagchi, and M.K. Bagchi A novel pathway involving progesterone receptor, 12/15-lipoxygenase-derived eicosanoids, and peroxisome proliferator-activated receptor gamma regulates implantation in mice J Biol Chem 279 2004 11570 11581 (Pubitemid 38401658)
27. Q.R. Pan, W.H. Li, H. Wang, Q. Sun, X.H. Xiao, and B. Brock Glucose, metformin, and AICAR regulate the expression of G protein-coupled receptor members in INS-1 beta cell Horm Metab Res 41 2009 799 804
28. P.K. Prabhakar, and M. Doble Synergistic effect of phytochemicals in combination with hypoglycemic drugs on glucose uptake in myotubes Phytomedicine 16 2009 1119 1122
29. B. Sung, S. Park, B.P. Yu, and H.Y. Chung Amelioration of age-related inflammation and oxidative stress by PPARγ activator: suppression of NF-κB by 2,4-thiazolidinedione Exp Gerontol 41 2006 590 599 (Pubitemid 43867228)
30. C.J. Glueck, A. Moriera, N. Goldenberg, L. Sieve, and P. Wang Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin Hum Reprod 18 2003 1618 1625 (Pubitemid 36958039)
31. R.S. Legro Pregnancy considerations in women with polycystic ovary syndrome Clin Obstet Gynecol 50 2007 295 304 (Pubitemid 46279868)
32. K. Subbaramaiah, D.T. Lin, J.C. Hart, and A.J. Dannenberg Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2: evidence for involvement of activator protein-1 and CREB-binding protein/p300 J Biol Chem 276 2001 12440 12448
33. V.A. Sander, G.B. Facorro, L. Piehl, E. Rubín de Celis, and A.B. Motta Effect of dehydroepiandrosterone and metformin on corpus luteum in mice Reproduction 138 2009 571 579
34. J.T. Huang, J.S. Welch, M. Ricote, C.J. Binder, T.M. Willson, and C. Kelly Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase Nature 400 1999 378 382 (Pubitemid 29344205)
35. R.L. Schild, W.T. Schaiff, M.G. Carlson, E.J. Cronbach, D.M. Nelson, and Y. Sadovsky The activity of PPAR γ in primary human trophoblasts is enhanced by oxidized lipids J Clin Endocrinol Metab 87 2002 1105 1110 (Pubitemid 36121074)
36. L. Nagy, P. Tontonoz, J.G. Alvarez, H. Chen, and R.M. Evans Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ Cell 93 1998 229 240 (Pubitemid 28180856)
37. Q. Chen, X. Sun, J. Chen, L. Cheng, J. Wang, Y. Wang, and Z. Sun Direct rosiglitazone action on steroidogenesis and proinflammatory factor production in human granulose-lutein cells Reprod Biol Endocrinol 7 2009 147 152
38. Y.P. Cheon, Q. Li, X. Xu, F.J. DeMayo, I.C. Bagchi, and M.K. Bagchi A genomic approach to identify novel progesterone receptor regulated pathways in the uterus during implantation Mol Endocrinol 16 2002 2853 2871 (Pubitemid 36020663)